Skip to main content

Advertisement

Log in

The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma

  • Original Article – Clinical Oncology
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

Abstract

Purpose

The role of adjuvant radiotherapy in patients with esophageal squamous cell carcinoma (ESCC) remains controversial. This retrospective study was designed to analyze the impact of adjuvant radiotherapy in patients with T3 stage ESCC after radical resection.

Methods

Data of a single-center cohort of 692 patients with T3 stage ESCC who underwent radical resection, with or without adjuvant radiotherapy, were reviewed. Univariate and multivariate analyses were performed to compare overall survival (OS) and locoregional recurrence-free survival (LRFS).

Results

Two hundred and forty-six patients received adjuvant radiotherapy (S + R group), and 446 patients underwent surgery alone (S group). The median survival time and 5-year OS rate were 40.0 months and 40.9 % for the entire population, 50.0 months and 45.6 % for the S + R group and 38.0 months and 38.3 % for the S group (P = 0.114 for S + R group vs. S group). The 5-year LRFS rate for the S + R group was significantly higher than that for S group (50.8 vs. 35.9 %, P < 0.001). In subgroup analyses, adjuvant radiotherapy was found to improve the 5-year OS in the subgroups of tumor length >5 cm, pN0 and pN1 categories, pTNM stage IIa, IIb and IIIa (P < 0.005).

Conclusions

Adjuvant radiotherapy is effective in local control of radically resected T3 stage ESCC and may improve the overall survival in certain subgroups, such as the patients with tumor length >5 cm, pN0 and pN1 categories, pTNM stage IIa, IIb and IIIa. Further studies are required to confirm our results.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Chen G, Wang Z, Liu XY, Liu FY (2009) Adjuvant radiotherapy after modified Ivor-Lewis esophagectomy: Can it prevent lymph node recurrence of the mid-thoracic esophageal carcinoma? Ann Thorac Surg 87:1697–1702. doi:10.1016/j.athoracsur.2009.03.060

    Article  PubMed  Google Scholar 

  • Chen J, Zhu J, Pan J, Zhu K, Zheng X, Chen M, Wang J, Liao Z (2010) Postoperative radiotherapy improved survival of poor prognostic squamous cell carcinoma esophagus. Ann Thorac Surg 90:435–442. doi:10.1016/j.athoracsur.2010.04.002

    Article  PubMed  Google Scholar 

  • Chen J, Pan J, Zheng X, Zhu K, Li J, Chen M, Wang J, Liao Z (2012) Number and location of positive nodes, postoperative radiotherapy, and survival after esophagectomy with three-field lymph node dissection for thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 82:475–482. doi:10.1016/j.ijrobp.2010.08.037

    Article  PubMed  Google Scholar 

  • Chen J, Pan J, Liu J, Li J, Zhu K, Zheng X, Chen M, Chen M, Liao Z (2013) Postoperative radiation therapy with or without concurrent chemotherapy for node-positive thoracic esophageal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 86:671–677. doi:10.1016/j.ijrobp.2013.03.026

    Article  PubMed  Google Scholar 

  • Cooper JS, Guo MD, Herskovic A, Macdonald JS, Martenson JA Jr, Al-Sarraf M, Byhardt R, Russell AH, Beitler JJ, Spencer S, Asbell SO, Graham MV, Leichman LL (1999) Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 281:1623–1627

    Article  PubMed  CAS  Google Scholar 

  • Crosby T, Evans M, Gillies RS, Maynard ND (2009) The management of a patient with an operable carcinoma of the oesophagus. Ann R Coll Surg Engl 91:366–370. doi:10.1308/003588409X432428

    Article  PubMed  PubMed Central  Google Scholar 

  • Fok M, Sham JS, Choy D, Cheng SW, Wong J (1993) Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study. Surgery 113:138–147

    PubMed  CAS  Google Scholar 

  • Fujita H, Sueyoshi S, Tanaka T, Shirouzu K (2002) Three-field dissection for squamous cell carcinoma in the thoracic esophagus. Ann Thorac Cardiovasc Surg 8:328–335

    PubMed  Google Scholar 

  • Hsu PK, Huang CS, Wang BY, Wu YC, Hsu WH (2014) Survival benefits of postoperative chemoradiation for lymph node-positive esophageal squamous cell carcinoma. Ann Thorac Surg 97:1734–1741. doi:10.1016/j.athoracsur.2013.12.041

    Article  PubMed  Google Scholar 

  • Huang W, Li B, Gong H, Yu J, Sun H, Zhou T, Zhang Z, Liu X (2010) Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with thoracic esophageal squamous cell carcinoma: a report of 1077 cases. Radiother Oncol 95:229–233. doi:10.1016/j.radonc.2010.01.006

    Article  PubMed  Google Scholar 

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61:69–90. doi:10.3322/caac.20107

    Article  PubMed  Google Scholar 

  • Law S, Arcilla C, Chu KM, Wong J (1998) The significance of histologically infiltrated resection margin after esophagectomy for esophageal cancer. Am J Surg 176:286–290

    Article  PubMed  CAS  Google Scholar 

  • Malthaner RA, Wong RK, Rumble RB, Zuraw L, Members of the Gastrointestinal Cancer Disease Site Group of Cancer Care Ontario’s Program in Evidence-based Care (2004) Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis. BMC Med 2:35. doi:10.1186/1471-2407-4-67

    Article  PubMed  PubMed Central  Google Scholar 

  • Schreiber D, Rineer J, Vongtama D, Wortham A, Han P, Schwartz D, Choi K, Rotman M (2010) Impact of postoperative radiation after esophagectomy for esophageal cancer. J Thorac Oncol 5:244–250. doi:10.1097/JTO.0b013e3181c5e34f

    Article  PubMed  Google Scholar 

  • Shridhar R, Weber J, Hoffe SE, Almhanna K, Karl R, Meredith K (2013) Adjuvant radiation therapy and lymphadenectomy in esophageal cancer: a SEER database analysis. J Gastrointest Surg 17:1339–1345. doi:10.1007/s11605-013-2192-7

    Article  PubMed  Google Scholar 

  • Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29. doi:10.3322/caac.21220

    Article  PubMed  Google Scholar 

  • Tam PC, Siu KF, Cheung HC, Ma L, Wong J (1987) Local recurrences after subtotal esophagectomy for squamous cell carcinoma. Ann Surg 205:189–194

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Ténière P, Hay JM, Fingerhut A, Fagniez PL (1991) Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. French University Association for Surgical Research. Surg Gynecol Obstet 173:123–130

    PubMed  Google Scholar 

  • van Hagen P, Hulshof MC, van Lanschot JJ, Steyerberg EW, van Berge Henegouwen MI, Wijnhoven BP, Richel DJ, Nieuwenhuijzen GA, Hospers GA, Bonenkamp JJ, Cuesta MA, Blaisse RJ, Busch OR, ten Kate FJ, Creemers GJ, Punt CJ, Plukker JT, Verheul HM, Spillenaar Bilgen EJ, van Dekken H, van der Sangen MJ, Rozema T, Biermann K, Beukema JC, Piet AH, van Rij CM, Reinders JG, Tilanus HW, van der Gaast A, CROSS Group (2012) Preoperative chemoradiotherapy for esophageal or junctional cancer. N Engl J Med 366:2074–2084. doi:10.1056/NEJMoa1112088

    Article  PubMed  Google Scholar 

  • Veeramachaneni NK, Zoole JB, Decker PA, Putnam JB Jr, Meyers BF, American College of Surgeons Oncology Group Z0060 Trial (2008) Lymph node analysis in esophageal resection: American College of Surgeons Oncology Group Z0060 trial. Ann Thorac Surg 86:418–421. doi:10.1016/j.athoracsur.2008.04.043

    Article  PubMed  Google Scholar 

  • Xiao ZF, Yang ZY, Liang J, Miao YJ, Wang M, Yin WB, Gu XZ, Zhang DC, Zhang RG, Wang LJ (2003) Value of radiotherapy after radical surgery for esophageal carcinoma: a report of 495 patients. Ann Thorac Surg 75:331–336

    Article  PubMed  Google Scholar 

  • Xiao ZF, Yang ZY, Miao YJ, Wang LH, Yin WB, Gu XZ, Zhang DC, Sun KL, Chen GY, He J (2005) Influence of number of metastatic lymph nodes on survival of curative resected thoracic esophageal cancer patients and value of radiotherapy: report of 549 cases. Int J Radiat Oncol Biol Phys 62:82–90. doi:10.1016/j.ijrobp.2004.08.046

    Article  PubMed  Google Scholar 

  • Yamamoto M, Yamashita T, Matsubara T, Kitahara T, Sekiguchi K, Furukawa M, Uki A, Kobayashi M, Tanaka E, Ueda M, Nakajima T (1997) Reevaluation of postoperative radiotherapy for thoracic esophageal carcinoma. Int J Radiat Oncol Biol Phys 37:75–78. doi:10.1016/S0360-3016(96)00473-7

    Article  PubMed  CAS  Google Scholar 

  • Zieren HU, Müller JM, Jacobi CA, Pichlmaier H, Müller RP, Staar S (1995) Adjuvant postoperative radiation therapy after curative resection of squamous cell carcinoma of the thoracic esophagus: a prospective randomized study. World J Surg 19:444–449. doi:10.1007/BF00299187

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yu-ping Chen.

Ethics declarations

Conflict of interest

All authors declare no conflicts of interest.

Additional information

Shao-bin Chen and Hong-rui Weng contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chen, Sb., Weng, Hr., Wang, G. et al. The impact of adjuvant radiotherapy on radically resected T3 esophageal squamous cell carcinoma. J Cancer Res Clin Oncol 142, 277–286 (2016). https://doi.org/10.1007/s00432-015-2041-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-015-2041-z

Keywords

Navigation